Oragenics, Inc. (OGEN) vs Silo Pharma, Inc. (SILO)
- Oragenics, Inc. OGEN 0.43 −2.27%
- Silo Pharma, Inc. SILO 1.18 −1.67%
Oragenics, Inc. and Silo Pharma, Inc. are both Biotechnology companies. Oragenics, Inc. and Silo Pharma, Inc. are of similar size ($2.0M and $1.9M). Silo Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Oragenics, Inc. trades at 0.4×. Silo Pharma, Inc. grew revenue faster over the last twelve months: 0.00% against −75.1%. Across the 13 metrics below, Silo Pharma, Inc. leads on 8 and Oragenics, Inc. on 5.
Valuation
Profitability
| Metric | OGEN | SILO | Biotechnology median |
|---|---|---|---|
| Gross margin | 19.89% | 11.81% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,307.07%) | (91.23%) | (56.36%) |
| Return on assets | (264.23%) | (70.96%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack